Published in Medical Devices and Surgical Technology Week, January 1st, 2006
Response Biomedical has received U.S. Food & Drug Administration (FDA) and Canadian regulatory clearance for its fluorescence-based Ramp Reader for general clinical use and three Ramp cardiac marker tests for detecting troponin I, CK-MB and myoglobin. LXU Medical, LXU healthcare's medical-surgical division will also distribute the company's NT-proBNP test which is expected to be available towards the end of 2006.
These rapid quantitative tests assist in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.